Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Xvivo Perfusion

180.10 SEK

-1.80 %

Less than 1K followers

XVIVO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xvivo Perfusion

2019202020212022202320242025
Revenue220.8179.9258.4415.3597.5822.4812.2
growth-%-18.6 %43.7 %60.7 %43.9 %37.6 %-1.2 %
EBITDA28.8-15.613.848.680.5176.1158.6
EBIT3.9-45.7-18.56.44.288.488.4
Profit before taxes5.3-57.36.722.394.5200.038.6
Net income4.9-43.78.218.491.8172.225.2
EPS0.19-1.620.280.623.075.470.80
Dividend0.000.000.000.000.000.000.00
Dividend ratio0.0 %-0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%13.0 %-8.7 %5.3 %11.7 %13.5 %21.4 %19.5 %
EBIT-%1.8 %-25.4 %-7.2 %1.5 %0.7 %10.7 %10.9 %
ROE0.9 %-4.3 %0.6 %1.3 %4.7 %8.0 %1.2 %
ROI0.8 %-3.8 %0.5 %1.1 %4.2 %7.2 %1.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.